A Phase III Clinical Study of WX390 Combined With Toripalimab Versus Investigator's Choice of Therapy in Patients With Recurrent or Metastatic Cervical Cancer Who Have Failed Prior Platinum-Based Treatment
Clinical trial NCT07392060 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07392060
- Sponsor
- Shanghai Jiatan Pharmatech Co., Ltd
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2029-09-30
- Enrollment
- 440
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.